Department of SBMC, Sapienza University Rome, Rome, Italy.
IRCCS "G.B. Bietti" Foundation, Neurophysiology of Vision and Neurophthalmology Unit, Rome, Italy.
J Neurol. 2016 Apr;263(4):781-3. doi: 10.1007/s00415-016-8066-7. Epub 2016 Feb 25.
SPG56 is an autosomal recessive form of hereditary spastic paraplegia (HSP) associated with mutations in CYP2U1. There is no clear documentation of visual impairment in the few reported cases of SPG56, although this form is complex on clinical ground and visual deficit are extremely frequent in complicated HSP. We report three patients in a consanguineous family harboring the novel homozygous c.1168C>T (p.R390*) in SPG56/CYP2U1, and showing a pigmentary degenerative maculopathy associated with progressive spastic paraplegia. Furthermore, we characterized precisely the ophthalmologic phenotype through indirect ophthalmoscopy, retinal optical coherence tomography and visual evoked potentials. This is the first formal report of pigmentary degenerative maculopathy associated with a CYP2U1 homozygous mutation.
SPG56 是一种常染色体隐性遗传性痉挛性截瘫(HSP),与 CYP2U1 基因突变有关。在少数报道的 SPG56 病例中,尽管这种形式在临床上很复杂,且在复杂 HSP 中视力缺陷极为常见,但并没有明确的视力损害记录。我们报道了一个家系中的 3 位患者,他们携带 SPG56/CYP2U1 中的新型纯合子 c.1168C>T(p.R390*),表现为进行性痉挛性截瘫伴色素性视网膜炎变性。此外,我们通过间接检眼镜、视网膜光学相干断层扫描和视觉诱发电位精确地描述了眼科表型。这是首次与 CYP2U1 纯合突变相关的色素性视网膜炎变性的正式报告。